These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 9701356)

  • 1. Gene therapy for lung cancer--an application for cationic lipid-mediated gene delivery?
    Scheule RK
    J Natl Cancer Inst; 1998 Aug; 90(15):1118-9. PubMed ID: 9701356
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel cationic solid lipid nanoparticles enhanced p53 gene transfer to lung cancer cells.
    Choi SH; Jin SE; Lee MK; Lim SJ; Park JS; Kim BG; Ahn WS; Kim CK
    Eur J Pharm Biopharm; 2008 Mar; 68(3):545-54. PubMed ID: 17881199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective treatment of early endobronchial cancer with regional administration of liposome-p53 complexes.
    Zou Y; Zong G; Ling YH; Hao MM; Lozano G; Hong WK; Perez-Soler R
    J Natl Cancer Inst; 1998 Aug; 90(15):1130-7. PubMed ID: 9701362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aerosol gene therapy for metastatic lung cancer using PEI-p53 complexes.
    Gautam A; Waldrep JC; Kleinerman ES; Xu B; Fung YK; T'Ang A; Densmore CL
    Methods Mol Med; 2003; 75():607-18. PubMed ID: 12407767
    [No Abstract]   [Full Text] [Related]  

  • 5. A novel cationic lipid with intrinsic antitumor activity to facilitate gene therapy of TRAIL DNA.
    Luo C; Miao L; Zhao Y; Musetti S; Wang Y; Shi K; Huang L
    Biomaterials; 2016 Sep; 102():239-48. PubMed ID: 27344367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesoscale computer modeling of lipid-DNA complexes for gene therapy.
    Farago O; Grønbech-Jensen N; Pincus P
    Phys Rev Lett; 2006 Jan; 96(1):018102. PubMed ID: 16486522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy for lung cancer and mesothelioma.
    Albelda SM
    Chest; 1997 Jun; 111(6 Suppl):144S-149S. PubMed ID: 9184568
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo gene therapy of human lung cancer using wild-type p53 delivered by retrovirus.
    Carbone DP; Minna JD
    J Natl Cancer Inst; 1994 Oct; 86(19):1437-8. PubMed ID: 8089857
    [No Abstract]   [Full Text] [Related]  

  • 9. Compositional effects of cationic lipid/DNA delivery systems on transgene expression in cell culture.
    Wiethoff CM; Koe JG; Koe GS; Middaugh CR
    J Pharm Sci; 2004 Jan; 93(1):108-23. PubMed ID: 14648641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model.
    Fujiwara T; Cai DW; Georges RN; Mukhopadhyay T; Grimm EA; Roth JA
    J Natl Cancer Inst; 1994 Oct; 86(19):1458-62. PubMed ID: 8089864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [What can be expected from gene therapy in respiratory diseases?].
    Mornex JF
    Presse Med; 1998 Apr; 27(16):769-70. PubMed ID: 9767903
    [No Abstract]   [Full Text] [Related]  

  • 12. p53 tumor suppressor gene therapy for cancer.
    Roth JA; Swisher SG; Meyn RE
    Oncology (Williston Park); 1999 Oct; 13(10 Suppl 5):148-54. PubMed ID: 10550840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aerosol gene delivery using viral vectors and cationic carriers for in vivo lung cancer therapy.
    Hong SH; Park SJ; Lee S; Cho CS; Cho MH
    Expert Opin Drug Deliv; 2015 Jun; 12(6):977-91. PubMed ID: 25423167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lung.
    Scheule RK; St George JA; Bagley RG; Marshall J; Kaplan JM; Akita GY; Wang KX; Lee ER; Harris DJ; Jiang C; Yew NS; Smith AE; Cheng SH
    Hum Gene Ther; 1997 Apr; 8(6):689-707. PubMed ID: 9113509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of cationic liposome formulations for intratracheal gene therapy of early lung cancer.
    Zou Y; Zong G; Ling YH; Perez-Soler R
    Cancer Gene Ther; 2000 May; 7(5):683-96. PubMed ID: 10830716
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete remission of multiple lung metastases after ablation of hepatocellular carcinoma by transarterial infusion with the p53 gene.
    Sheng S; Zheng J; Cui S; Cui X; Qian Z
    Anticancer Drugs; 2015 Feb; 26(2):227-31. PubMed ID: 25243455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyridinium cationic lipids in gene delivery: an in vitro and in vivo comparison of transfection efficiency versus a tetraalkylammonium congener.
    Ilies MA; Johnson BH; Makori F; Miller A; Seitz WA; Thompson EB; Balaban AT
    Arch Biochem Biophys; 2005 Mar; 435(1):217-26. PubMed ID: 15680924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular and genetic aspects of lung cancer.
    Rom WN; Hay JG; Lee TC; Jiang Y; Tchou-Wong KM
    Am J Respir Crit Care Med; 2000 Apr; 161(4 Pt 1):1355-67. PubMed ID: 10764334
    [No Abstract]   [Full Text] [Related]  

  • 19. Aerosolization of cationic lipid:pDNA complexes--in vitro optimization of nebulizer parameters for human clinical studies.
    Eastman SJ; Tousignant JD; Lukason MJ; Chu Q; Cheng SH; Scheule RK
    Hum Gene Ther; 1998 Jan; 9(1):43-52. PubMed ID: 9458241
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector.
    Ramesh R; Saeki T; Templeton NS; Ji L; Stephens LC; Ito I; Wilson DR; Wu Z; Branch CD; Minna JD; Roth JA
    Mol Ther; 2001 Mar; 3(3):337-50. PubMed ID: 11273776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.